(Q73245479)

English

Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte

scientific article published on 01 October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

follicular lymphoma

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

B Coiffier

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E M Neidhardt-Bérard

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Tilly

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Belanger

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Bouabdallah

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Brice

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Y Péaud

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J L Pico

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Janvier

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Solal-Celigny

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Brousse

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1191-1197

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008347425795

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008347425795

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008347425795

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008347425795

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008347425795

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008347425795

7 January 2021

based on heuristic

inferred from DOI database lookup

A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008347425795

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008347425795

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10586336%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73245479&oldid=1947011082"